Enterprise Financial Services Corp Siga Technologies Inc Transaction History

Enterprise Financial Services Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 30, 2019	SELL	$5.22 - $6.1 $4,238 - $4,953	-812 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$5.66 - $7.89 $4,595 - $6,406	812 New	812 $5,000

215

35.2M

74.6K

22.8K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.